Showing 681 - 700 results of 147,133 for search '(( 2 a decrease ) OR ( 5 ((((wt decrease) OR (nn decrease))) OR (teer decrease)) ))', query time: 1.41s Refine Results
  1. 681
  2. 682
  3. 683
  4. 684
  5. 685
  6. 686

    Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

    Published 2009
    “…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
  7. 687

    Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

    Published 2009
    “…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
  8. 688

    Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

    Published 2009
    “…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
  9. 689

    Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

    Published 2009
    “…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
  10. 690

    Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

    Published 2009
    “…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
  11. 691

    Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

    Published 2009
    “…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
  12. 692

    Corticosterone treatment decreases MMP-2 promoter activity. by Eric A. Shikatani (131260)

    Published 2012
    “…Whole cell lysates were used for qRT-PCR. MMP-2 mRNA levels were decreased with corticosterone treatment (A) (p = 0.006, n = 5). …”
  13. 693
  14. 694
  15. 695
  16. 696
  17. 697
  18. 698
  19. 699
  20. 700

    NatB inactivation decreased the level of MAPK and proposed model of EGFR/MAPK signaling regulation by NatB and the N-end rule pathways. by Zhentao Sheng (107495)

    Published 2020
    “…In contrast, low NatB activity and low Ac-CoA levels will reduce the levels of Nt-acetylated Grb2/Drk, MAPK, and PP2AC, leading to reduced EGFR signaling due to decreased levels of Grb2/Drk and MAPK (positive components of the pathway) and increased levels of PP2AC (negative component of the pathway). …”